Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epirich is a dermatological product line developed by Silamed, primarily focused on skin barrier repair and hydration. The portfolio includes Epirich Moisturizing Lotion, Epirich PE Moisturizing Cleanser, and Epirich Cera Daily Moisturizing Lotion. The Epirich Cera formulation utilizes ceramides, phytosphingosine, and cholesterol to restore the skin's lipid bilayer, while the Epirich PE variant incorporates palmitoylethanolamide (PEA) to provide anti-inflammatory and anti-pruritic effects, likely through PPAR-alpha activation. These products are indicated for the management of dry skin conditions, atopic dermatitis, and sensitive skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Epirich.